- President Trump signed an executive order enforcing healthcare price transparency, requiring hospitals and insurers to disclose actual costs.
- The order aims to make medical pricing more accessible, reinforcing a 2019 policy that faced legal challenges but was upheld in court.
U.S. President Donald Trump signed an executive order on Tuesday aimed at strengthening healthcare price transparency. The order directs the Departments of the Treasury, Labor, and Health and Human Services to enforce a 2019 policy requiring hospitals and insurers to disclose actual prices for medical services and prescription drugs.
The directive calls for updating regulations to ensure that price information is standardised and publicly accessible. It also instructs agencies to revise enforcement policies to hold hospitals and insurers accountable for compliance.
Trump emphasized the importance of price transparency in healthcare, stating,
"You're not allowed to even talk about it when you're going to a hospital or see a doctor. And this allows you to go out and talk about it. It's been unpopular in some circles because people make less money, but it's great for the patient."
The original 2019 policy required hospitals to display pricing information for 300 common services and provide machine-readable files detailing negotiated rates for all services. It also mandated that health insurers disclose their negotiated rates with providers, out-of-network payments, and prescription drug costs through an online tool for consumers.
Hospital groups challenged the rule in court, arguing that it forced them to disclose confidential negotiations with insurers, undermining competition and violating their First Amendment rights. However, the courts rejected these claims, upholding the policy.
Proponents of price transparency argue that making healthcare costs public allows consumers and employers to compare prices and make more informed decisions, potentially leading to significant savings.
According to an economic analysis, full implementation of Trump's price transparency regulations could generate $80 billion in savings by 2025.
Some critics, however, contend that while transparency may help, it does not directly address the high costs of medical care. They argue that structural changes to the healthcare system, including insurance and provider pricing models, are necessary for more substantial cost reductions.
The enforcement of these regulations has been a contentious issue. The Biden administration faced criticism and legal challenges for not fully enforcing prescription drug transparency requirements. With the new order, Trump seeks to reestablish and reinforce his approach to making healthcare pricing more accessible to patients and employers.
Healthcare price transparency remains a key issue for many Americans, with surveys indicating that a majority consider it a priority. Whether this executive order will lead to meaningful changes in how patients navigate healthcare costs remains to be seen.
Edited by Harshajit Sarmah
